Skip to content
value.today

Torus Biosystems, Inc.

Total raised
$29 M
3 rounds on record
Latest round
$25 M
Apr 2021
First round on record
Jan 2020
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Torus Biosystems, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2021$25 MNo. 3$10 to $50 million

Torus Biosystems, Inc.: Raise no. 3, Apr 2021

Investors in this round

6 investors had bought by the notice of May 5, 2021: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$25 M of $25 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ben Linden · Executive Officer
  • Shawn Marcell · Executive Officer, Director
  • Adam Yu Wiechhaus · Director
  • David Yu Zhang · Director
  • Peng Yin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Shawn Marcell, President and CEO. Source: SEC Form D, newest notice filed May 5, 2021. Read the notice at the SEC.

equitySEC
Dec 2020$2 MNo. 2$2 to $10 million

Torus Biosystems, Inc.: Raise no. 2, Dec 2020

Investors in this round

4 investors had bought by the notice of Mar 18, 2021: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ben Linden · Executive Officer
  • Shawn Marcell · Executive Officer, Director
  • David Yu Zhang · Director
  • Peng Yu Yin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Shawn Marcell, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Mar 18, 2021. Read the notice at the SEC.

debt, optionsSEC
Jan 2020$2 MNo. 1Under $2 million

Torus Biosystems, Inc.: Raise no. 1, Jan 2020

Investors in this round

1 investor had bought by the notice of Feb 7, 2020: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Peng Yin · Executive Officer, Director
  • Philip Gardella · Executive Officer
  • Chenyang Victor Shi · Director
  • David Yu Zhang · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Peng Yin, President. Source: SEC Form D, newest notice filed Feb 7, 2020. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Torus Biosystems, Inc. chose not to state its revenue in its newest notice of a funding round (May 2021).

    SEC Form D · May 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2021

That is all the official record says: Torus Biosystems, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Torus Biosystems, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 6 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Torus Biosystems, Inc.
NameRoleNamed in
Ben LindenExecutive officerMay 2021
Shawn MarcellExecutive officerMay 2021
Peng YinExecutive officerFeb 2020
Philip GardellaExecutive officerFeb 2020
Adam Yu WiechhausDirectorMay 2021
David Yu ZhangDirectorMay 2021
Peng YinDirectorMay 2021
Shawn MarcellDirectorMay 2021
Peng Yu YinDirectorMar 2021
Chenyang Victor ShiDirectorFeb 2020